Treatment | CCRT group (n = 49) | IC plus RT group (n = 49) | IC plus CCRT group (n = 49) | P value |
---|---|---|---|---|
RT dose (Gy) | Â | Â | Â | 0.004* |
 Median (range) | 68 (68–72) | 70 (68–72) | 70 (68–72) |  |
RT days | Â | Â | Â | 0.419* |
 Median (range) | 44 (40–54) | 43 (40–54) | 44 (40–55) |  |
IC regimen |  |  |  | 0.838†|
 PF | - | 28 (57.1 %) | 29 (59.2 %) |  |
 TP | - | 21 (42.9 %) | 20 (40.8 %) |  |
IC cycles |  |  |  | 0.170†|
 Two cycles | - | 33 (67.3 %) | 39 (79.6 %) |  |
 Three cycles | - | 16 (32.7 %) | 10 (20.4 %) |  |
CCRT cycles |  |  |  | 0.233†|
 Two cycles | 40 (81.6 %) | - | 45 (91.8 %) |  |
 Three cycles | 9 (18.4 %) | - | 4 (8.2 %) |  |